| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/19/2007 | EP1865984A1 Immunogenic compositions comprising lawsonia intracellularis |
| 12/19/2007 | EP1865979A2 Treatment of cognitive and learning impairment |
| 12/19/2007 | EP1865773A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
| 12/19/2007 | EP1616012B1 Synthetic bi-directional promoters and uses thereof |
| 12/19/2007 | EP1578366A4 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use |
| 12/19/2007 | EP1557469B1 Method of expressing protein having unnatural amino acid integrated thereinto |
| 12/19/2007 | EP1305435B1 Use of herpes simplex virus glycoprotein d to suppress immune responses |
| 12/19/2007 | EP1230369B1 Polypeptide hormone phosphatonin |
| 12/19/2007 | EP0772689B1 Retroviral vectors having a reduced recombination rate |
| 12/19/2007 | EP0594669B2 Growth factor-responsive neural progenitor cells which can be proliferated in vitro. |
| 12/19/2007 | CN101089186A Expression carrier for human L-type complement agglutinant fibre gelled protein and construction and application |
| 12/19/2007 | CN101088565A Use of miRNA-34a |
| 12/19/2007 | CN100355781C 肽 Peptide |
| 12/19/2007 | CN100355458C Use of artificial proliferative inhibiting gene-adenovirus expression carrier |
| 12/18/2007 | US7309814 Nucleic acid molecules encoding bacterial autoinducer inactivation protein as targets for engineering disease resistance |
| 12/18/2007 | US7309760 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 12/18/2007 | US7309757 Polymers for the delivery of bioactive agents and methods of their preparation |
| 12/18/2007 | US7309695 Pharmaceutical compositions for the prevention and treatment of atherosclerosis and restenosis after PTCA |
| 12/18/2007 | US7309692 Inhibition of Grb2 and Crk1 gene products that interact with the bcr-abl product and participate in the transformation of Chronic myeloid leukemia |
| 12/18/2007 | US7309604 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 12/18/2007 | US7309598 gM-negative EHV-mutants |
| 12/18/2007 | US7309578 Administering an antagonist inhibiting apoptosis of lung cells, diagnosing the disease |
| 12/18/2007 | US7309487 Administering antibody that specifically binds to a matrix metalloproteinase membrane-associated 1 (MT1-MMP) protein for therapy of age-related macular degeneration |
| 12/18/2007 | CA2249390C Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor |
| 12/13/2007 | WO2007143584A2 RNAi-MEDIATED INHIBITION OF STROMAL CELL-DERIVED FACTOR 1-RELATED TARGETS FOR TREATMENT OF NEOVASCULARIZATION-RELATED CONDITIONS |
| 12/13/2007 | WO2007143538A2 Pike-a enhances infection by myxoma virus |
| 12/13/2007 | WO2007143317A2 Compounds and methods for modulating expression of crp |
| 12/13/2007 | WO2007143316A2 Compounds and methods for modulating expression of sglt2 |
| 12/13/2007 | WO2007143315A2 Compounds and methods for modulating expression of pcsk9 |
| 12/13/2007 | WO2007143086A2 Delivery method |
| 12/13/2007 | WO2007142792A2 Potent inhibition of influenza virus by specifically designed short interfering rna |
| 12/13/2007 | WO2007142754A2 Methods and compositions for cognitive alteration |
| 12/13/2007 | WO2007142304A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 12/13/2007 | WO2007142303A1 Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 12/13/2007 | WO2007142139A1 Method of identifying candidate for remedy of acute myeloid leukemia |
| 12/13/2007 | WO2007141971A1 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity |
| 12/13/2007 | WO2007141796A2 Therapeutic uses of inhibitors of rtp801l |
| 12/13/2007 | WO2007141737A2 Targeted gene expression for the treatment of primary tumors, and a therapeutic extension to the treatment of metastases. |
| 12/13/2007 | WO2007141346A2 Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases |
| 12/13/2007 | WO2007141005A1 Use of glutamyl aminopeptidase (enpep) as a therapeutic or diagnostic target |
| 12/13/2007 | WO2007141004A1 Use of adipsin (adn) as a therapeutic or diagnostic target |
| 12/13/2007 | WO2007140906A1 Use of leucyl/cystinyl aminopeptidase (lnpep) as a therapeutic or diagnostic target |
| 12/13/2007 | WO2007140618A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease |
| 12/13/2007 | WO2007140590A1 Methods and compositions for inducing bone synthesis |
| 12/13/2007 | WO2007084815A3 Substituted thienopyrimidine kinase inhibitors |
| 12/13/2007 | WO2006084243A3 Compositions and methods for the therapeutic treatment of diabetes |
| 12/13/2007 | WO2005113019A3 Methods for the treatment of autoimmune diseases |
| 12/13/2007 | US20070287682 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 12/13/2007 | US20070287679 Ornithine aminotransferase (OAT): a target for anticancer drugs |
| 12/13/2007 | US20070287678 Anti-aging micrornas |
| 12/13/2007 | US20070287677 Rad51 Expression Inhibitors, Pharmaceutical Agents Containing The Inhibitors As Active Ingredients, And Uses Thereof |
| 12/13/2007 | US20070287175 Sirna That Inhibits Wt1 Gene Expression And Uses Thereof |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070287163 Methods for Diagnosis of Acute Myeloid Leukemia |
| 12/13/2007 | US20070287153 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection |
| 12/13/2007 | US20070287150 Methods And Compositions Involving S-Ship Promoter Regions |
| 12/13/2007 | US20070286860 Compositions and Methods for Inducing Anti-Tumor Immunity |
| 12/13/2007 | US20070286856 Enzyme is a drug target; cancer, inflammatory diseases such as psoriasis |
| 12/13/2007 | US20070286848 Epas1 Gene Transfer to Improve Cell Therapy |
| 12/13/2007 | US20070286846 Novel methods for ester detoxication |
| 12/13/2007 | US20070286845 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 12/13/2007 | US20070286843 Recombinant Polypeptides of the Members of the Tnf Ligand Family and Use Thereof |
| 12/13/2007 | US20070286806 Methods and Compositions for Modulating a Steroid Receptor |
| 12/13/2007 | CA2657946A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease |
| 12/12/2007 | EP1865066A2 Genetic immunisation against cervical carcinoma |
| 12/12/2007 | EP1865065A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 12/12/2007 | EP1865062A2 Altered OspA of Borrelia burgdorferi |
| 12/12/2007 | EP1864997A1 ROR ALPHA PROMOTING THE INDUCTION OF Bmal1 EXPRESSION |
| 12/12/2007 | EP1864134A2 Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
| 12/12/2007 | EP1863514A2 Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases |
| 12/12/2007 | EP1766053A4 Rna-containing microvesicles and methods therefor |
| 12/12/2007 | EP1511857B1 Pthrp-based prediction and diagnosis of bone disease |
| 12/12/2007 | EP1490492B1 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 12/12/2007 | EP1432803B1 Fragments of the human zn-alpha2-glycoprotein and their use in methods of treatment of obesity |
| 12/12/2007 | EP1355668B1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
| 12/12/2007 | EP1137792B9 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 12/12/2007 | EP1000144B1 Lactoferrin receptor gene of moraxella |
| 12/12/2007 | EP0927174B1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds |
| 12/12/2007 | EP0894130B1 Modulators of tnf receptor associated factor (traf), their preparation and use |
| 12/12/2007 | CN101087623A Antisense oligonucleotides for treating allergy and neoplastic cell proliferation |
| 12/12/2007 | CN101087620A Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter |
| 12/12/2007 | CN101085986A SARS coronavirus disturbance RNA and its uses |
| 12/12/2007 | CN101085363A Application of liver cell growth factor gene |
| 12/12/2007 | CN101085360A Use of chitosan quaternary ammonium salt/rectorite nano composite material |
| 12/12/2007 | CN101085357A Non-virus nano nucleic acid transferring composite for curing gristle defection by injecting in joint cavity and preparing method thereof |
| 12/12/2007 | CN101085356A Non-virogene transfection carrier, complex particles of the same and plasmid DNA, preparing method and using method |
| 12/12/2007 | CN101085346A Attenuated pestiviruses |
| 12/12/2007 | CN100354431C Method of PCR testing of pooled blood samples |
| 12/12/2007 | CN100354426C Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 12/12/2007 | CN100354004C Tubercle bacillus chimeric gene vaccine and preparation process thereof |
| 12/11/2007 | US7307143 Conductin protein and a related agent for diagnosing and treating tumor illnesses |
| 12/11/2007 | US7307101 Administering N-hydroxy-N-(4-butyl-2-methylphenyl)-formamidine (HET0016) to increase or prevent a decrease in cerebral blood flow |
| 12/11/2007 | US7307069 Inflammatory diseases and cancers; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
| 12/11/2007 | US7307068 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products |
| 12/11/2007 | US7307067 Methods and compositions for reducing viral genome amounts in a target cell |
| 12/11/2007 | US7307066 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 12/11/2007 | US7306927 Diagnosing cancer in humans; obtain sample, detect expression of chymotrypsin, presence of chymotrypsin enzyme indicates cancer |
| 12/11/2007 | US7306920 Gene associated with regulation of energy balance, obesity and diabetes and uses therefor |
| 12/11/2007 | US7306908 Mutant Dna; transcription of genomes |
| 12/11/2007 | US7306902 Detecting ras-activated neoplastic cells by contacting sample with a reovirus and determining its ability to replicate; use in diagnosis and treatment of interferon-sensitive, p53/Rb deficient tumors |